Energy and Isotopes for Medicine

Beyond electricity, fusion machines produce neutrons and isotopes that medicine relies on — a health dividend alongside the clean-power one.

Vision, not specification. This page describes a future that fusion could help make possible — not a product promise, forecast, or performance claim. The Kronos machines today are design and simulation studies: the breeder (Hyperion) and the burner (Aegis / MetroVolt). No hardware net-gain has been demonstrated; construction of the first breeder is planned to begin in Q2 2027, with first-of-a-kind first tritium targeted around 2030.

More than power

A fusion machine is a source of energetic neutrons and, by design, of specific isotopes. The breeder (Hyperion) is a deuterium–tritium spherical tokamak whose designed products include 14 MeV neutrons and a tritium-class output, alongside helium-3. Those outputs have uses far beyond the grid, and medicine is among the most important.

Medical imaging and certain cancer treatments depend on a reliable supply of specific isotopes, several of which are today produced in ageing reactors and are prone to shortage. A neutron source designed for steady operation could help stabilize that supply — a public-health benefit that rides alongside the energy mission.

Why this belongs in the vision

The vision is a healthier world, and health is not only clean air and water. A dependable domestic source of medical isotopes reduces the fragility of a supply chain that patients quietly depend on. It is a concrete way that fusion’s benefits reach people who will never think about plasma physics.

The honest frame

• The neutron and isotope outputs are frozen design figures, not delivered production.
• Isotope supply is a broad field; fusion is one potential contributor.
• No economic or market claims are made — this is a capability, not a business claim.

See the outward-facing side in fusion and space and the compute link in computing and discovery.